What does ProQR Therapeutics NV do?

Jun 22 2025 06:51 PM IST
share
Share Via
ProQR Therapeutics N.V. is a pre-clinical biopharmaceutical company focused on developing RNA-based therapies for severe genetic disorders. As of March 2025, it has a market cap of $205.86 million, with net sales of $5 million and a net loss of $11 million.
Overview:
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for severe genetic disorders, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 5 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -11 Million (Quarterly Results - Mar 2025)
Market-cap: USD 205.86 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.62
Return on Equity: -38.80%
Price to Book: 2.41

Contact Details:
Address: Zernikedreef 9, LEIDEN None: 2333 CK
Tel: 31 854 894932
Website: https://www.proqr.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is ProQR Therapeutics NV technically bullish or bearish?
Sep 20 2025 07:56 PM IST
share
Share Via
Is ProQR Therapeutics NV overvalued or undervalued?
Sep 20 2025 06:29 PM IST
share
Share Via
Is ProQR Therapeutics NV overvalued or undervalued?
Jun 25 2025 09:07 AM IST
share
Share Via
Is ProQR Therapeutics NV technically bullish or bearish?
Jun 25 2025 08:54 AM IST
share
Share Via
Who are in the management team of ProQR Therapeutics NV?
Jun 22 2025 10:38 PM IST
share
Share Via
How big is ProQR Therapeutics NV?
Jun 22 2025 06:07 PM IST
share
Share Via